TY  - GEN
AU  - Smits,Mark M
AU  - Tonneijck,Lennart
AU  - Muskiet,Marcel H A
AU  - Hoekstra,Trynke
AU  - Kramer,Mark H H
AU  - Diamant,Michaela
AU  - Nieuwdorp,Max
AU  - Groen,Albert K
AU  - Cahen,Djuna L
AU  - van Raalte,Daniël H
TI  - Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
SN  - 1463-1326
PY  - 2017///1107
KW  - Aged
KW  - Bile Acids and Salts
KW  - metabolism
KW  - Blood Glucose
KW  - Chenodeoxycholic Acid
KW  - Cholic Acid
KW  - Deoxycholic Acid
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - therapeutic use
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Fasting
KW  - Feces
KW  - chemistry
KW  - Female
KW  - Gallbladder
KW  - diagnostic imaging
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Liraglutide
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Organ Size
KW  - Postprandial Period
KW  - Sitagliptin Phosphate
KW  - Sulfonylurea Compounds
KW  - Ultrasonography
KW  - Ursodeoxycholic Acid
KW  - Glucagon-Like Peptide-1 Receptor Agonists
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12748
ER  -